Repose Clinic And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 15-11-2024
- Paid Up Capital ₹ 2.00 M
as on 15-11-2024
- Company Age 28 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.50 M
as on 15-11-2024
- Revenue -15.67%
(FY 2023)
- Profit -98.46%
(FY 2023)
- Ebitda -28.79%
(FY 2023)
- Net Worth 0.06%
(FY 2023)
- Total Assets 8.28%
(FY 2023)
About Repose Clinic And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company has closed loans amounting to ₹0.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Asit Ghosh, Shakuntala Ghose, and Mayarani Ghose serve as directors at the Company.
- CIN/LLPIN
U85110WB1996PTC077698
- Company No.
077698
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Feb 1996
- Date of AGM
11 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Repose Clinic And Research Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mayarani Ghose  | Managing Director | 29-Feb-1996 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Asit Ghosh | Director | 09-Aug-2022 | Current |
| Shakuntala Ghose | Director | 24-Mar-2015 | Current |
Financial Performance of Repose Clinic And Research Centre.
Repose Clinic And Research Centre Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.67% decrease. The company also saw a substantial fall in profitability, with a 98.46% decrease in profit. The company's net worth moved up by a moderate rise of 0.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Repose Clinic And Research Centre?
In 2022, Repose Clinic And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Creation Date: 24 Dec 2001 | ₹0.50 M | Satisfied |
How Many Employees Work at Repose Clinic And Research Centre?
Repose Clinic And Research Centre has a workforce of 81 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Repose Clinic And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Repose Clinic And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
